You are here

Responses

Article menu

Download PDFPDF

Editorial
Changing Tobacco Control's policy on tobacco industry-funded research
Free
Compose a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on: 13 May 2016
    Re:Consequences of TC policy

    NOT PEER REVIEWED Prof. Ruth Malone is a real, well known catalyst in controlling use of tobacco worldwide. Now her one very sharp weapon to control tobacco use is to implement a policy in terms of rejecting tobacco industry funded research manuscripts publication. There are currently hundreds of thousands of journals including open access journals and are these journals going to follow the steps of TC policy of TCJ? If t...

    Show More
    Conflict of Interest:
    None declared.
  • Published on: 13 May 2016
    Implementing Tobacco Control's policy on tobacco industry-funded research.

    NOT PEER REVIEWED The decision to ban tobacco industry-funded research in the Journal could be the opportunity for pointless byzantine discussions from the pros and cons.(1) However, the issue is more concrete. First, Ruth Malone acknowledged the editorial board for vigorous discussions and I would like to know how many members opposed the ban. Second, what is the definition of a tobacco industry for the Journal? Cancer R...

    Show More
    Conflict of Interest:
    None declared.
  • Published on: 13 May 2016
    Consequences of TC policy

    Although I disagree with TC's policy to prohibit publication of research from the tobacco industry, I do understand the rationale for this decision. My concern is illustrated by the following scenario. Assume a pharmaceutical company owned by a tobacco industry has truly developed a safer tobacco/nicotine product; e.g. a nicotine inhaler, submits it to the US FDA or the UK MHRA. Both of these agencies have stated they w...

    Show More
    Conflict of Interest:
    None declared.